Manufacturer
BAYER AG
Contents
Regorafenib
Indication
Metastatic colorectal cancer; Unresectable, metastatic malignant GI stromal tumours
Instruction
Should be taken with food. Take at the same time each day w/ a low-fat meal (<30% fat).
Drug interaction
Increased exposure w/ strong CYP3A4 inhibitors (e.g. ketoconazole). Decreased exposure w/ strong CYP3A4 inducers (e.g. rifampicin).
Malaysia
